
|Videos|July 28, 2016
CINV: Understanding the Guidelines for Recommendations
Advertisement
Episodes in this series

James Natale, PharmD, BCOP, outlines the guidelines for acute and delayed emesis in patients receiving highly emetic chemotherapy versus moderately emetic chemotherapy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
Up to 5 Cups of Coffee Daily Safe—and Benficial—for Most Adults
3
Pharmacist Outreach Doubles SGLT2 Inhibitor Uptake in CKD
4
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
5













































































































